Gene Therapy’s Slow Start

Multimillion-dollar gene therapies were long awaited and desired, but patients were unsure whether insurance would cover the costs. So far, very few patients are taking gene therapy — even as few as four or five people. Does the slow rollout show a disconnect between cutting-edge science and patient benefit? Read more here.

Source: LA Kelley Communications, Inc., Communique, September 2024